Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Peiyuantongnao capsule registry study in recovery-phase ischemic stroke
ChiCTR1900023273Phase 4Not yet recruiting
- Sponsor
- Dongzhimen Hospital of Beijing University of Traditional Chinese Medicine
- Start
- Nov 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of peiyuan tongnao in ischemic stroke, sponsored by Dongzhimen Hospital of Beijing University of Traditional Chinese Medicine. Primary endpoint: Degree of disability. Planned start Nov 2018; status: not yet recruiting.
02
Drugs
peiyuan tongnao
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on ChiCTR1900023273.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900023273.